Summary:
The purpose of the study is to evaluate the safety and tolerability of multiple doses of NPT088 in patients with mild to moderate probable Alzheimer's Disease. The study will also evaluate the pharmacokinetics, immunogenicity and exploratory pharmacodynamic characteristics of multiple doses of NPT088.
Qualified Participants Must:
• Be between the ages of 50-85
•
Have probable Alzheimer's Disease
•
Have a dedicated caregiver
Qualified Participants May Receive:
May be compensated for their time and travel